Sector
Expertise

Life
Sciences

Life Sciences

For nearly two decades, we’ve assisted pharmaceutical, biotechnology, consumer health, diagnostic, digital health, and medical device organisations in attracting and developing senior executives.

Whether you are a start-up, an established corporation, or a CMO, and working on pre-clinical or clinical development, or commercialisation, we’ll help you build collaborative teams. We are skilled in customising our approach to attract diverse, globally-experienced leaders for science-driven environments.

Graphic

Key Trends in Life Sciences

Diversity

Global patient demographics, emerging market demands and opportunities, and an increasingly female talent pool require inclusive leadership. Business leaders must become adept at recognising and prioritising the importance of diversity to harness its advantages for business and society.

1

Collaboration

New business models require collaborative approaches to pipeline innovation, manufacturing and supply, and myriad bench-to-bedside translations. This matrix of layered initiatives requires leaders at all levels of the organisation to be capable of cutting across traditional disciplines through influence, persuasion and compromise.

2

Precision and Personalised Medicine

The scientific advances that are giving rise to precision and personalised medicine are some of the great disruptors of our time. The radical changes that will emerge require leaders to be highly flexible, broad thinkers, who are comfortable challenging and ultimately dismantling the status quo.

3

Value-Driven Patient Access in a Limited Resource Healthcare Ecosystem

Long-term strategic planners who can realistically assess risk and make tough R&D decisions are needed to lead life science companies. They must provide value-driven access to a wide variety of customers and stakeholders in a healthcare ecosystem with limited resources, as well as develop innovative products and therapies. Alternative channels to market will be an inevitable component of any new strategy.

4

Diversity

Global patient demographics, emerging market demands and opportunities, and an increasingly female talent pool require inclusive leadership. Business leaders must become adept at recognising and prioritising the importance of diversity to harness its advantages for business and society.

5

Big Data, Digitalization, and Artificial Intelligence

Big data collection and usage; digitalization; and artificial intelligence in the entire life-cycle of therapies, from development to the point of patient access, are unstoppable trends. Wielding these technology tools in a meaningful way requires innovation leadership that is balanced by well-defined change management skills and a keen ability to prioritise.

Latest News in Life Sciences

November 22, 2019

Amgen juices up sales outlook amid high hopes for Celgene castoff Otezla

Life sciences

When Amgen said it would hand over $13.4 billion for Celgene’s hit psoriasis drug Otezla in August, analysts agreed it had overpaid by $2 billion. But they also predicted Amgen’s […]

November 21, 2019

Sanofi CEO’s strategy blueprint may include consumer health spinoff or merger: Bloomberg

Life sciences

Sanofi CEO Paul Hudson has been on the job for just over two months, and he’s prepping for a big strategy reveal next month. One thing that might be behind […]

November 21, 2019

The Medicines Company surges on rumours of Novartis takeover

Life sciences

Shares in The Medicines Company have leapt on rumours that Novartis is eyeing a takeover of the company and its promising new cardiovascular drug inclisiran. A report from Bloomberg also […]

Subscribe to our Weekly Newsletter

Understanding your business is our business